Assignee
ENDECE LLC
US·4 granted patents·3 pending applications·8 citations·filing 2006–2022
Top patents by PatentIndex Score
7 records- 0181US7846918B2Exemestane compounds, compositions and related methods of useENDECE LLC·Filed 2006·Granted Dec 7, 2010·6 cites·17 claims
- 0270US9636348B26-substituted estradiol derivatives for use in remyelination of nerve axonsENDECE LLC·Filed 2016·Granted May 2, 2017·1 cites·14 claims
- 0369US9422324B26-substituted demethyl-estradiol derivatives as selective ER-β agonistsENDECE LLC·Filed 2014·Granted Aug 23, 2016·1 cites·22 claims
- 0466US2023097440A1Methods for modulation of lipoprotein lipase and apolipoprotein c2 expression and/or activity in the treatment of peripheral and central nervous system tissue disease statesENDECE LLC·Filed 2022·Application pending·0 cites
- 0557US2021024568A1Methods for modulation of lipoprotein lipase and apolipoprotein c2 expression and/or activity in the treatment of peripheral and central nervous system tissue disease statesENDECE LLC·Filed 2020·Application pending·0 cites
- 0656US10723757B26-substituted estradiol derivatives and methods of useENDECE LLC·Filed 2019·Granted Jul 28, 2020·0 cites·24 claims
- 0732US2015265630A16-Substituted Estradiol Derivatives for the Treatment of Alzheimer's DiseaseENDECE LLC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →